Donna Valencia

Donna Valencia has over 16 years of work experience in the pharmaceutical industry. Donna began their career in 2004 as a Pharmacist at Walgreens, and then moved on to Omnicare in 2006. In 2007, they took on the role of Drug Safety Specialist at Ranbaxy. From 2008 to 2011, they were Manager of Drug Safety and Surveillance at Ikaria Holdings. After that, they joined Pfizer in 2011 as Manager of Product Safety and Surveillance Reporting. In 2013, they became Associate Director of PVRM, Safety Information Management at Forest Laboratories. In 2014, they were promoted to Senior Manager of Pharmacovigilance at Mesoblast. From 2017 to 2022, they held the positions of Senior Director and Vice President of Head of Patient Safety and Epidemiology at Sio Gene Therapies. Since 2022, they have been Vice President, Head of Drug Safety at Immune-Onc Therapeutics.

Donna Valencia holds a Bachelor of Science in Physiology and Neurobiology from the University of Maryland, an MBA from the University of Baltimore, and a Doctor of Pharmacy from the University of Maryland Baltimore.